Episodebeskrivelse
Despite significant scientific progress in neuroscience, clinical trial success rates remain low. Complex diseases, evolving therapeutic approaches and challenges around endpoint selection continue to make development difficult.
As biomarkers, AI and precision medicine become increasingly integrated into clinical research, sponsors have new opportunities to strengthen study design, improve patient selection and make more informed development decisions throughout the clinical development journey.
This podcast explores:
-Why endpoint selection remains one of the greatest challenges in…

